全文获取类型
收费全文 | 3971篇 |
免费 | 292篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 149篇 |
妇产科学 | 115篇 |
基础医学 | 441篇 |
口腔科学 | 93篇 |
临床医学 | 319篇 |
内科学 | 870篇 |
皮肤病学 | 58篇 |
神经病学 | 342篇 |
特种医学 | 133篇 |
外国民族医学 | 5篇 |
外科学 | 724篇 |
综合类 | 119篇 |
一般理论 | 1篇 |
预防医学 | 254篇 |
眼科学 | 73篇 |
药学 | 291篇 |
中国医学 | 32篇 |
肿瘤学 | 236篇 |
出版年
2023年 | 38篇 |
2022年 | 89篇 |
2021年 | 144篇 |
2020年 | 94篇 |
2019年 | 114篇 |
2018年 | 142篇 |
2017年 | 89篇 |
2016年 | 101篇 |
2015年 | 115篇 |
2014年 | 164篇 |
2013年 | 190篇 |
2012年 | 260篇 |
2011年 | 290篇 |
2010年 | 183篇 |
2009年 | 159篇 |
2008年 | 195篇 |
2007年 | 208篇 |
2006年 | 202篇 |
2005年 | 245篇 |
2004年 | 192篇 |
2003年 | 173篇 |
2002年 | 153篇 |
2001年 | 76篇 |
2000年 | 68篇 |
1999年 | 80篇 |
1998年 | 27篇 |
1997年 | 26篇 |
1996年 | 17篇 |
1995年 | 30篇 |
1994年 | 16篇 |
1993年 | 19篇 |
1992年 | 28篇 |
1991年 | 20篇 |
1990年 | 27篇 |
1989年 | 21篇 |
1988年 | 18篇 |
1987年 | 17篇 |
1986年 | 24篇 |
1985年 | 20篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1979年 | 12篇 |
1978年 | 21篇 |
1973年 | 11篇 |
1972年 | 14篇 |
1971年 | 11篇 |
1969年 | 15篇 |
1966年 | 10篇 |
排序方式: 共有4286条查询结果,搜索用时 15 毫秒
51.
52.
53.
Steven R. Passmore Michael G. Johnson Saleh M. Aloraini Stephan Cooper Mina Aziz Cheryl M. Glazebrook 《Journal of manipulative and physiological therapeutics》2019,42(1):23-33
ObjectiveThe purpose of this study was to quantify the impact of a single lumbar spinal manipulation (SM) intervention on the leg movement performance of degenerative lumbar spinal stenosis (LSS) patients in a small-scale registered randomized clinical trial.MethodsParticipants with LSS (n = 14) were tested at baseline for pain, lumbar range of motion, and behavioral or kinematic motor performance (using an established Fitts’ Law foot-pointing task), then underwent covariate adaptive randomization to receive SM or no intervention. Postintervention all dependent measures were repeated. Experimenters were blinded to patient group allocation. University ethics board approval was attained.ResultsFor the primary outcome movement time, there was no significant difference between groups. As predicted by Fitts’ Law, all participants had longer movement times as task difficulty increased. Secondary kinematic outcomes yielded no significant between-group differences. Consistent with Fitts’ Law, kinematic measures changed significantly with task difficulty. Pairwise comparisons revealed the kinematic variables were more adversely affected by greater movement amplitudes than target size changes. No exploratory differences in pain or lumbar range of motion were observed.ConclusionChanges in motor performance were not observed in this chronic pain population after a single SM intervention compared with a control group. Given the sample size, the study may have been underpowered to detect meaningful differences. Fitts’ Law was observed for the lower extremity–pointing task for an LSS population and may provide an objective measure of motor performance. 相似文献
54.
El.H. Kabiri M. Caidi S. Al Aziz A. El Maslout A. Benosman 《Acta chirurgica Belgica》2013,113(4):401-404
Objective: A retrospective review of 79 cases of ruptured intrapleural pulmonary hydatid cysts. We analyse and evaluate our experience in the surgical treatment of this complication.Materials and Methods: In a ten-year period, from 1990 to 1999, 79 patients were operated on in our service for intrapleural rupture of a pulmonary hydatid cyst. There were 51 males and 28 females with a mean age of 35.4 years. The diagnosis was established on the basis of different clinical signs and imaging studies.Surgical approach consisted of a posterolateral thoracotomy in all cases. After decortication, different procedures were performed on the pulmonary lesions according to the importance of lung destruction.Results: Radical resections were done in 48 cases, including lobectomies (15), segmentectomies (33) and conservative treatment: simple capitonnage and bronchial fistula closure (31).Postoperative complications occurred in 8 cases (10.1%), including one pyothorax, one haemothorax, one prolonged air leak, two pneumonias and two wound infections.There was one postoperative death, by respiratory failure. Ninety-five percent (95%) of patients were free of recurrence of thoracic hydatid disease in a follow-up ranging from 1 to 10 years (mean: 5.4 years).Conclusion: Hydatid cysts of the lung should be treated before complications occur, particularly intrapleural rupture because it considerably increases morbidity. 相似文献
55.
Susanne Halken Desiree Larenas‐Linnemann Graham Roberts Moises A. Calderón Elisabeth Angier Oliver Pfaar Dermot Ryan Ioana Agache Ignacio J. Ansotegui Stefania Arasi George Du Toit Montserrat Fernandez‐Rivas Roy Geerth van Wijk Marek Jutel Jörg Kleine‐Tebbe Susanne Lau Paolo M. Matricardi Giovanni B. Pajno Nikolaos G. Papadopoulos Martin Penagos Alexandra F. Santos Gunter J. Sturm Frans Timmermans R. van Ree Eva‐Maria Varga Ulrich Wahn Maria Kristiansen Sangeeta Dhami Aziz Sheikh Antonella Muraro 《Pediatric allergy and immunology》2017,28(8):728-745
Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond cessation of AIT that may include important preventive effects. The European Academy of Allergy and Clinical Immunology (EAACI) has developed a clinical practice guideline to provide evidence‐based recommendations for AIT for the prevention of (i) development of allergic comorbidities in those with established allergic diseases, (ii) development of first allergic condition, and (iii) allergic sensitization. This guideline has been developed using the Appraisal of Guidelines for Research & Evaluation (AGREE II) framework, which involved a multidisciplinary expert working group, a systematic review of the underpinning evidence, and external peer‐review of draft recommendations. Our key recommendation is that a 3‐year course of subcutaneous or sublingual AIT can be recommended for children and adolescents with moderate‐to‐severe allergic rhinitis (AR) triggered by grass/birch pollen allergy to prevent asthma for up to 2 years post‐AIT in addition to its sustained effect on AR symptoms and medication. Some trial data even suggest a preventive effect on asthma symptoms and medication more than 2 years post‐AIT. We need more evidence concerning AIT for prevention in individuals with AR triggered by house dust mites or other allergens and for the prevention of allergic sensitization, the first allergic disease, or for the prevention of allergic comorbidities in those with other allergic conditions. Evidence for the preventive potential of AIT as disease‐modifying treatment exists but there is an urgent need for more high‐quality clinical trials. 相似文献
56.
Sina Aziz 《临床与转化肝病杂志(英文版)》2014,2(4):247-252
The treatment of hepatitis c virus (HCV) infection in children is difficult as few options are available. The standard therapy is combination pegylated interferon (PEG–IFN) α-2a or 2b and ribavirin, and the duration of therapy depends on HCV genotype. New oral drug therapies available for adults have still not been approved for treatment in children. Here, we review the causes of HCV infection in children, the therapeutic options for children, and the side effects of these treatments. The problems faced by physicians managing HCV infection in children less than 12 years of age in a developing country are also discussed. 相似文献
57.
AndrewJ. Stott Michel C. Maillard Vahri Beaumont David Allcock Omar Aziz Alexander H. Borchers Wesley Blackaby Perla Breccia Gillian Creighton-Gutteridge Alan F. Haughan Rebecca E. Jarvis Christopher A. Luckhurst Kim L. Matthews George McAllister Scott Pollack Elizabeth Saville-Stones Amanda J. Van de Poël Huw D. Vater Julie Vann Rachel Williams Dawn Yates Ignacio Muoz-Sanjun Celia Dominguez 《ACS medicinal chemistry letters》2021,12(3):380
Using an iterative structure–activity relationship driven approach, we identified a CNS-penetrant 5-(trifluoromethyl)-1,2,4-oxadiazole (TFMO, 12) with a pharmacokinetic profile suitable for probing class IIa histone deacetylase (HDAC) inhibition in vivo. Given the lack of understanding of endogenous class IIa HDAC substrates, we developed a surrogate readout to measure compound effects in vivo, by exploiting the >100-fold selectivity compound 12 exhibits over class I/IIb HDACs. We achieved adequate brain exposure with compound 12 in mice to estimate a class I/IIb deacetylation EC50, using class I substrate H4K12 acetylation and global acetylation levels as a pharmacodynamic readout. We observed excellent correlation between the compound 12 in vivo pharmacodynamic response and in vitro class I/IIb cellular activity. Applying the same relationship to class IIa HDAC inhibition, we estimated the compound 12 dose required to inhibit class IIa HDAC activity, for use in preclinical models of Huntington’s disease. 相似文献
58.
59.
Iris Schrijver Nazneen Aziz Daniel H. Farkas Manohar Furtado Andrea Ferreira Gonzalez Timothy C. Greiner Wayne W. Grody Tina Hambuch Lisa Kalman Jeffrey A. Kant Roger D. Klein Debra G.B. Leonard Ira M. Lubin Rong Mao Narasimhan Nagan Victoria M. Pratt Mark E. Sobel Karl V. Voelkerding Jane S. Gibson 《The Journal of molecular diagnostics : JMD》2012,14(6):525-540
60.